What is Sleepcogni?
Founded in 2015 and headquartered in the United Kingdom, Sleepcogni is dedicated to advancing the diagnosis and monitoring of insomnia and co-existing health and sleep disorders. The company's core innovation lies in its in-home monitoring and biofeedback system, designed to provide sleep clinicians with crucial data. This technology aims to enhance diagnostic accuracy and enable more effective patient management, positioning Sleepcogni as a key player in the digital health and medical device market.
How much funding has Sleepcogni raised?
Sleepcogni has raised a total of $2.7M across 2 funding rounds:
Other Financing Round
$660K
Unspecified
$2M
Other Financing Round (2021): $660K, investors not publicly disclosed
Unspecified (2021): $2M led by Chasnay Capital Partners
Key Investors in Sleepcogni
Chasnay Capital Partners
Chasnay Capital Partners is an investor participating in the company's funding round. Their specific investment focus is not detailed, but their involvement suggests a strategic interest in Sleepcogni's market potential.
What's next for Sleepcogni?
The substantial enterprise-level funding and recent strategic investment indicate that Sleepcogni is poised for significant expansion and further development of its innovative biofeedback system. This capital infusion will likely fuel advancements in product research and development, enhance clinical validation, and support market penetration efforts. The company's focus on addressing complex sleep and health disorders suggests a strategic roadmap aimed at capturing a larger share of the growing sleep technology market and solidifying its position as a leader in clinician-supported home sleep monitoring solutions.
See full Sleepcogni company page
